Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhang Wang

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2020
The efficiency of <sup>18</sup>F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancerXiuli Tao, Ning Li, Ning Wu, et al.
Expert Opinion on Drug Delivery|March 15, 2021
Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trendsYue Wang, Xinyi Tan, Xinyu Fan, et al.
EMBO Molecular Medicine|May 15, 2026
Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasionShouyan Deng, Yuan Fang, Jieyuan Xue, et al.
Drug Discovery Today|November 12, 2022
Breaking boundaries: Current progress of anticancer NK cell-based drug developmentShuhang Wang, Kun Chen, Yale Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 13, 2022
Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLCFan Zhang, Wei Guo, Bolun Zhou, et al.
Frontiers in Molecular Biosciences|April 1, 2022
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese PatientsShuhang Wang, Qin Li, Peiwen Ma, et al.
Acta Pharmaceutica Sinica. B|June 3, 2024
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrierQiyu Tang, Guo Zhao, Hong Fang, et al.
Oncology|September 12, 2012
EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancerZhijie Wang, Xuchao Zhang, Hua Bai, et al.
Thoracic Cancer|March 13, 2020
Retrospective analysis of the effectiveness and tolerability of nab-paclitaxel in Chinese elderly patients with advanced non-small-cell lung carcinomaShuhang Wang, Qiuping Liang, Yujia Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung CancerJiangyong Yu, Shuhang Wang, Wei Zhao, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2020
The efficiency of <sup>18</sup>F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancerXiuli Tao, Ning Li, Ning Wu, et al.
Expert Opinion on Drug Delivery|March 15, 2021
Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trendsYue Wang, Xinyi Tan, Xinyu Fan, et al.
EMBO Molecular Medicine|May 15, 2026
Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasionShouyan Deng, Yuan Fang, Jieyuan Xue, et al.
Drug Discovery Today|November 12, 2022
Breaking boundaries: Current progress of anticancer NK cell-based drug developmentShuhang Wang, Kun Chen, Yale Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 13, 2022
Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLCFan Zhang, Wei Guo, Bolun Zhou, et al.
Frontiers in Molecular Biosciences|April 1, 2022
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese PatientsShuhang Wang, Qin Li, Peiwen Ma, et al.
Acta Pharmaceutica Sinica. B|June 3, 2024
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrierQiyu Tang, Guo Zhao, Hong Fang, et al.
Oncology|September 12, 2012
EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancerZhijie Wang, Xuchao Zhang, Hua Bai, et al.
Thoracic Cancer|March 13, 2020
Retrospective analysis of the effectiveness and tolerability of nab-paclitaxel in Chinese elderly patients with advanced non-small-cell lung carcinomaShuhang Wang, Qiuping Liang, Yujia Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung CancerJiangyong Yu, Shuhang Wang, Wei Zhao, et al.
Pageof 19